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OBJECTIVE—To identify genes that confer susceptibility to au-
toimmune diabetes following viral infection in the LEW.1WR1 rat.
RESEARCH DESIGN AND METHODS—About 2% of
LEW.1WR1 rats develop spontaneous autoimmune diabetes. Im-
munological perturbants including viral infection increase both
the frequency and tempo of diabetes onset. To identify diabetes
susceptibility genes (LEW.1WR1  WF), F2 rats were infected
with Kilham rat virus following brief pretreatment with poly-
inosinic:polycytidylic acid. This treatment induces diabetes in
100% of parental LEW.1WR1 rats and 0% of parental WF rats.
Linkage to diabetes was analyzed by genome-wide scanning.
RESULTS—Among 182 F2 rats, 57 (31%) developed autoim-
mune diabetes after a mean latency of 16 days. All diabetic
animals and 20% of nondiabetic animals exhibited pancreatic
insulitis. Genome-wide scanning revealed a requirement for the
Iddm14 locus, long known to be required for diabetes in the BB
rat. In addition, a new locus near the RT1 major histocompati-
bility complex (MHC) was found to be a major determinant of
disease susceptibility. Interestingly, one gene linked to autoim-
mune diabetes in mouse and human, UBD, lies within this region.
CONCLUSIONS—The Iddm14 diabetes locus in the rat is a
powerful determinant of disease penetrance in the LEW.1WR1
rat following viral infection. In addition, a locus near the MHC
(Iddm37) conditions diabetes susceptibility in these animals.
Other, as-yet-unidentiﬁed genes are required to convert latent
susceptibility to overt diabetes. These data provide insight into
the polygenic nature of autoimmune diabetes in the rat and the
interplay of genetic and environmental factors underlying dis-
ease expression. Diabetes 58:2930–2938, 2009
T
he precise cause of human type 1 diabetes is
unknown but may involve the interaction of
genetic susceptibility alleles at many loci with
the environment (1). In particular, viral infection
has been proposed as the “trigger” of autoimmune destruc-
tion of pancreatic -cells (2,3). Much effort has gone into
identifying both the host genes and microbial agent(s)
whose combined effects lead to disease. Identiﬁcation of
human type 1 diabetes genes has proven difﬁcult, however,
because disease-associated alleles are common, and even
the highest-risk genotypes confer only modest risk of
disease (4,5). Studying environmental factors is also difﬁ-
cult because the human population is exposed randomly
to microbial agents, and the role of viral infection in the
disease has remained controversial (6).
In contrast, animal models can be inbred and tested in
controlled environments. Two widely used models of
autoimmune diabetes are nonobese diabetic (NOD) mice
(7) and BB rats (8). More than 30 mouse loci are linked to
diabetes, some of which are orthologues of human non–
major histocompatibility complex (MHC) loci identiﬁed by
genome-wide association studies (GWASs) (9,10). With
respect to the environment, however, NOD mice may
model type 1 diabetes poorly (11) because most viral
infections reduce disease frequency (12–14). Only Cox-
sackie virus accelerates disease in NOD mice (15), but it is
associated with exocrine pancreatitis (16), which is un-
characteristic of human type 1 diabetes (17,18). For these
reasons, the NOD mouse has not been informative for
modeling the virus-diabetes relationship or the genetic
basis for this interaction.
The relevance of autoimmune diabetes in spontaneously
diabetic BBDP rats to human disease has been questioned
because they are congenitally lymphopenic. Nonetheless,
recent studies show that diabetes susceptibility in this
animal is linked to MHC- and non–MHC-linked genetic loci
that are orthologous to human GWAS loci (19). BBDR and
LEW.1WR1 rats, which rarely become spontaneously hy-
perglycemic, share many of these loci and are susceptible
to viral triggering of type 1 diabetes (8,20–22). Suscepti-
bility to triggering by speciﬁc viruses in these rats is
variable, and linkage studies will be helpful for dissecting
the genetic basis for the virus-diabetes relationship.
BBDR rats (23) never develop spontaneous hyperglyce-
mia in clean housing but readily develop diabetes after
infection with Kilham rat virus (KRV), a parvovirus (20).
Natural infection induces diabetes in 1% of animals;
injection of virus induces diabetes in 30–40% (20). Infec-
tion with KRV following brief pretreatment with three
nondiabetogenic doses of polyinosinic:polycytidylic acid
(poly I:C), a ligand of Toll-like receptor 3, leads to diabetes
in 100% of animals (21). Poly I:C is a ligand of Toll-like
receptor 3 and by itself is nondiabetogenic at this dose
(21). KRV does not infect -cells, and susceptibility is virus
speciﬁc; H-1, which is 98% sequence identical, never
induces diabetes (21,24). WF rats (bearing the same high-
risk RT1
u class II allele as BBDR) are susceptible to
infection with KRV but are completely resistant to both
spontaneous and virus-induced diabetes (21).
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for predisposition to virus-induced diabetes (“Iddm” loci)
using linkage assessment in F2 rats (25). One locus,
Iddm14 (formerly Iddm4), is a dominant factor in KRV-
induced diabetes in the BBDR strain (25). A second locus,
Iddm20, on chromosome 17, is required for full penetrance
of Iddm14 (25). Importantly, congenic WF.Iddm14
DR rats
that bear only the BB origin allele of Iddm14 are resistant to
KRV-induced diabetes (25).
LEW.1WR1 rats are genetically distinct from BBDR rats
(26). They bear an unusual MHC recombinant haplotype
RT1A
uB/D
uC
a (27) that includes the class II “u” alleles that
are generally required for autoimmune diabetes in the rat
(28). They develop spontaneous diabetes at a low rate
(2.5%) but readily develop diabetes during chronic treat-
ment with poly I:C (22). They also become diabetic follow-
ing exposure not only to KRV but also cytomegalovirus
and vaccinia virus (29,30).
In the present report, we have determined the genetic
control of virus-induced diabetes in the LEW.1WR1 rat
strain. Despite the genetic divergence of the BB and LEW
parental strains, we show that both rats require permissive
alleles at Iddm14. However, unlike BBDR rats, LEW.1WR1
rats also require an MHC-linked gene for KRV-induced
diabetes. Taken together, these studies illustrate the ge-
netic complexity of susceptibility to autoimmune diabetes
in the rat.
RESEARCH DESIGN AND METHODS
LEW.1WR1 (RT1A
uB/D
uC
a, ART2a) rats were obtained from Biomedical
Research Models (Worcester, MA). WF.ART2 rats (RT1u/u, ART2a) were
developed by us and obtained from the colony at the University of Massachu-
setts Medical School; they differ from ordinary WF animals in that they
express the BB origin “a” rather than the “b” allotype of the ART2 T-cell
alloantigen (25,31). WF.ART2a rats do not develop diabetes either spontane-
ously or in response to KRV infection (25). WF.ART2 animals are referred to
as WF in this report. (LEW.1WR1  WF) F2 rats were bred by us, housed in
viral antibody–free conditions, conﬁrmed monthly to be serologically free of
rat pathogens (31), and maintained according to guidelines of the institutional
animal care and use committees of the University of Massachusetts, Biochem-
ical Research Models, and the Guide for the Care and Use of Laboratory
Animals (32).
Induction of diabetes. Diabetes was induced using KRV (University of
Massachusetts) propagated in normal rat kidney cells (ATCC CRL-6509) as
described (25). Poly I:C (Sigma, St. Louis, MO) was dissolved in Dulbecco’s
PBS, sterile ﬁltered, and stored at 20°C until used. Contaminating endotoxin
concentration was 50 units/mg (Charles River Endosafe, Charleston, SC).
Rats 21–25 days of age of either sex were injected intraperitoneally with poly
I:C (1 g/g body wt) on days 3, 2, and 1 and with KRV (10
7 plaque-
forming units) on day 0. We have previously observed that this short course of
poly I:C does not itself elicit diabetes but does increase the frequency of
diabetes in KRV-treated LEW.1WR1 rats from 40 to 100% (R.S. Tirabassi,
D.L.Gr., E.P.B., J.H. Leif, B.A. Woda, Z. Lui, D.A. Winans, D.L.Gu., J.P.M.,
unpublished data). LEW.1WR1 rats injected chronically with poly I:C (1 g/g
three times per week) become diabetic within 2 weeks (22); we used this
protocol to elicit diabetes in rats intended for certain gene expression studies.
Animals were screened three times weekly for glycosuria (Tes-Tape; Eli Lilly,
Indianapolis, IN) for 40 days. Diabetes was diagnosed on the basis of plasma
glucose concentrations 250 mg/dl (OneTouch Ultra Glucometer; LifeS-
can, Milpitas, CA).
Histology. To quantify insulitis, pancreata were harvested and ﬁxed in 10%
formalin; 10- sections were stained with hematoxylin and eosin and scored
by light microscopy on a scale of 0 to 4 as described (31).
Genotyping and linkage. DNA samples were prepared from tail snips or
liver samples and genotyped using microsatellite markers as described
(25,31). LEW.1W and LEW.1A genomic DNA samples were the gift of Dr. Dirk
Wedekind (Hanover, Germany). Genotypes for 133 evenly distributed micro-
satellite markers were collected in the Map Manager QT program and
exported for further analysis to Windows Quantitative Trait Locus (QTL)
Cartographer, version 2.5 (33). Severity of insulitis and days to onset (nondi-
abetic rats being scored as 41 days) were used as the quantitative subpheno-
typic parameters of diabetes in this QTL analysis. Composite interval mapping
was performed using model 6 to identify QTL peaks with a signiﬁcant
likelihood ratio test (LRT) statistic. Permutation analyses to establish thresh-
olds of signiﬁcance were performed using Map Manager QT, set for 1,000
permutations of the data (34).
Sequence analyses. High-ﬁdelity Taq polymerase (Platinum PCR Supermix
High Fidelity; Invitrogen) was used to amplify genomic DNA or cDNA, and
these products were used as sequencing templates. Primers for ampliﬁcation
were designed using the BN rat genome sequence (available at genome.
ucsc.edu) and Primer 3 software (available at http://frodo.wi.mit.edu/
primer3).
In addition to full sequences, single nucleotide polymorphisms (SNPs)
were typed on chromosome 20 using the phototyping technique (35). Two
alternate allele-speciﬁc SNP primers and one common opposite-strand primer
were designed for each SNP using Primer 3 to have a Tmelt of 58–60°C, where
the allele-speciﬁc primer has a 3	 nucleotide that matches one of two SNP
alleles. SNP haplotypes were assembled in an Excel database and used to
delineate the breakpoints of the recombinant chromosome 20 in LEW.1WR1
rats. Only SNPs that distinguish the two LEW.1WR1 parental strains, LEW.1A
and LEW.1W (26), are shown in this report.
Gene expression data. cDNA was prepared from rat spleen and mesenteric
lymph node RNA using the Omniscript RT Kit 200 (Qiagen). Primers for rat
UBD (diubiquitin), TNF (tumor necrosis factor), IFN- (interferon-y), and
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) were designed from rat
genomic sequences as above (online appendix Table 1 [available at http://
diabetes.diabetesjournals.org/cgi/content/full/db09-0387/DC1]). Quantitative
real-time PCR was performed using SYBR Green PCR mix on an ABI 7900
sequence detector.
Data analysis. Life tables were analyzed using the method of Kaplan and
Meier and log-rank statistics (36). Parametric data are given as arithmetic
means 
 SD. Two-group comparisons used unpaired t tests, and comparisons
of three or more groups used ANOVA. Real-time quantitative PCR data were
analyzed with the Mann-Whitney test and ANOVA. Two-tailed P values 0.05
are considered statistically signiﬁcant. Genetic interaction between two QTL
was assessed using one-way ANOVA adding in each factor (QTL) sequentially.
RESULTS
Autoimmune diabetes in (LEW.1WR1  WF) F2 rats.
In a preliminary study, 97% of LEW.1WR1 rats (29 of 30)
developed diabetes after a 3-day low-dose pretreatment
with poly I:C followed by 10
7 plaque-forming units of KRV.
None of six rats became diabetic after this brief course of
poly I:C alone. We then tested (LEW.1WR1  WF) F1 rats
using the same protocol, and 44% (26/59) became diabetic
with an average latency of 15.5 days.
To generate a linkage map of Iddm loci, we then created
a cohort of 182 (LEW.1WR1  WF) F2 rats and, again,
treated them with the same induction protocol. Of these,
57 became diabetic (31%; 27% of females and 36% of males,
P  0.22). Average latency to diabetes among sick animals
was statistically similar in male and female rats (16.4 
 2.7
and 16.2 
 2.9 days, respectively; P  not signiﬁcant).
Pancreata obtained from 175 (LEW.1WR1  WF) F2 rats
were scored for insulitis. Among diabetic rats, mean
histological score was 3.7 
 0.5 with no scores 3.
Among nondiabetic rats, the mean insulitis score was
0.6 
 0.8 (range 0 to 2; P  0.0001 vs. diabetic rats); only
19.5% (25 of 128) had insulitis with scores of 1 to 2.
The Iddm14 locus is a signiﬁcant determinant of
diabetes in (LEW.1WR1  WF) F2 rats. We predicted
that Iddm14 and/or Iddm20 would be important for
diabetes induction by KRV following poly I:C in
LEW.1WR1 rats, just as they are required for KRV-induced
BBDR diabetes (25). Therefore, we prepared genomic
DNA samples from 182 (LEW.1WR1  WF) F2 animals and
genotyped them for markers that identify the Iddm14 and
Iddm20 intervals on chromosomes 4 and 17, respectively.
Iddm14 (as marked by its canonical microsatellite marker
D4Arb9 [37]) was highly signiﬁcantly linked to diabetes in
this cohort. All 57 diabetic F2 rats bore at least one
E.P. BLANKENHORN AND ASSOCIATES
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10
11, Fisher 2  3 exact probability test). There was no
linkage to the Iddm20 QTL on chromosome 17 (25), which
segregated randomly in this cohort with respect to diabe-
tes in both the total F2 (P  0.493) and in those F2 rats
bearing at least one copy of the susceptible Iddm14
L allele
(P  0.434).
A new locus, Iddm37, enhances penetrance of
Iddm14. As we observed for the (BBDR  WF) F2 cross
(25), not all (LEW.1WR1 WF) F2 rats with diabetogenic
Iddm14 alleles became sick during the 40-day observation
period. Only 41% (36 of 91) of heterozygotes and 57% (21 of
37) of Iddm14
L/L homozygous rats were diabetic, indicat-
ing that another gene (that is not Iddm20 [25] on chromo-
some 17) is required for diabetes in this strain combination
(Table 1). We therefore conducted a full genome scan of
F2 to ﬁnd this QTL.
Permutation analysis of the dataset revealed that “sug-
gestive” linkage for a QTL required an LRT 10.5; “signif-
icant” linkage, an LRT 17.5; and “highly signiﬁcant”
linkage, an LRT 25.7. Our ﬁrst QTL, Iddm14, has a
remarkably high LRT of 49 (Fig. 1), and it is therefore a
highly signiﬁcant predictor of diabetes in this strain com-
bination. A second QTL was found on chromosome 20
(Fig. 1), and we provisionally designate it Iddm37. It is a
signiﬁcant predictor of diabetes and severity of insulitis in
this F2 cohort (LRT  19.5 and LRT  29, respectively).
Iddm37 acts by modifying the penetrance of Iddm14.
The Iddm14 locus was signiﬁcantly linked to increased
diabetes incidence only when rats carried at least one
LEW.1WR1-derived allele of D20Rat47, which, at 2.8 Mb
from the top of chromosome 20, serves as the closest-
linked marker for Iddm37. Among 128 rats bearing a
susceptible allele of Iddm14, there was a signiﬁcant
increase in diabetes frequency in Iddm37
L/L (46%), or
TABLE 1
Iddm14 is required but not sufﬁcient for diabetes expression in
the (LEW.1WR1  WF) F2 progeny
Genotype* Number
Days to
onset
Diabetic rats Iddm14 W/W 0 NA
Iddm14 L/W 36 16.6 
 2.8
Iddm14 L/L 21 15.8 
 2.8
Total 57
Nondiabetic rats Iddm14 W/W 54 NA
Iddm14 L/W 55 NA
Iddm14 L/L 16 NA
Total 125
Data are means 
 SD, unless otherwise indicated. The 182
(LEW.1WR1  WF) F2 rats described in RESEARCH DESIGN AND METHODS
were divided into diabetic and nondiabetic categories after a 40-day
observation period. Within each group, animals were subcategorized
according to their inheritance of Iddm14 alleles: Iddm14 W/W,
homozygous for WF-derived alleles at Iddm14; Iddm14 L/W, het-
erozygous; and Iddm14 L/L, homozygous for LEW.1WR1-derived
alleles at Iddm14. Shown in the ﬁnal column are the mean latencies
to diabetes in each cohort. NA, not applicable (not diabetic).
*Signiﬁcance of linkage of diabetes to Iddm14 is P  1.5  10
11
(Fisher exact probability 2  3 test).
0.0
9.8
19.6
29.4
39.2
49.0 LR0
cM
12 3 4 5 6 7 8 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 1 9 2 0
FIG. 1. Composite interval analysis of linkage to the diabetes subphenotypes of insulitis and latency to onset in 182 (LEW.1WR1  WF) F2 rats
was performed as described in RESEARCH DESIGN AND METHODS. The QTLs for insulitis are depicted by solid lines and the QTLs for latency by dashed
lines; the LRT scale is on the y-axis. Suggestive (10.2) and signiﬁcant (17.2) LRT score cutoffs are indicated by horizontal lines. The peaks of each
of the latency QTLs (on chromosome 4, D4Arb9 and D4Got43; and on chromosome 20, D20Rat47) correspond to an LRT of 48.3 and 19.5,
respectively (the equivalent LOD scores are 10.52 and 4.53, respectively). For insulitis, Iddm14 is linked with an LRT of 38.5 at the peak marker
and Iddm37 an LRT of 29.01 (LOD scores of 8.38 and 6.31, respectively).
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L/W (63%) animals compared with Iddm37
W/W rats
(19%, P  0.0001, 
2 test) (Table 2). Thus, while diabetes
was absolutely dependent on the presence of at least one
LEW.1WR1-derived allele of Iddm14, diabetes penetrance
was signiﬁcantly enhanced in those rats that also bore
LEW.1WR1 alleles at Iddm37 (Fig. 2).
No other QTLs were signiﬁcantly linked to diabetes
incidence, latency, or insulitis in the genome scan of the
whole F2 cohort (Fig. 1). However, among the diabetic
animals, we noted a signiﬁcant linkage of latency to
Iddm24 (Fig. 3), a diabetes latency QTL originally discov-
ered in a cross between WF and BBDP rats (38). In both
crosses, Iddm24 was marked by microsatellite markers at
110–120 Mb distal to the centromere. Among diabetic rats,
WF-derived alleles of Iddm24 were protective when ho-
mozygous and prolonged latency from 14.5 
 2 days in
Iddm24
L/L rats to 17.6 
 2 days in Iddm24
W/W rats (P 
0.0056).
Candidate genes in the Iddm37 locus. Iddm37 is
located in the extended RT1C region of the MHC, which is
known to differ among LEW.1W, LEW.1A, WF, and
LEW.1WR1 rats (39). Because LEW.1WR1 rats bear a
recombinant MHC haplotype, it remained to be deter-
mined which of three independent MHC-linked haplotypes
(LEW.1A, LEW.1W, or the LEW background) contributed
the diabetes-promoting allele that we identiﬁed as the
Iddm37 QTL. The original mapping of LEW.1WR1 sug-
gested that the RT1C region in LEW.1WR1 rats was
donated by LEW.1A. To conﬁrm this, we conducted an
extensive SNP analysis of the chromosome 20 region
TABLE 2
Permissive LEW.1WR1 alleles at Iddm37 increase diabetes susceptibility in F2 rats that bear permissive alleles at Iddm14
Iddm37 L/L Iddm37 L/W Iddm37 W/W
Diabetic Well Total Diabetic Well Total Diabetic Well Total
Iddm14 L/L or L/W 12 (46%) 14 26 37 (63%) 22 59 8 (19%) 35 43
Iddm14 W/W 0 11 11 0 30 30 0 12 12
Total 12 25 37* 37 52 89† 8 47 55‡
Among 182 (LEW.1WR1  WF) F2 rats subjected to our diabetes induction protocol as described in RESEARCH DESIGN AND METHODS, we analyzed
129 that carried at least one LEW.1WR1 origin allele at Iddm14 (either Iddm14 L/L or Iddm14 L/W, row 3) or two WF origin alleles (row
4). These two genetic categories were then subdivided according to their Iddm37 genotype. The columns present the number and percent
of diabetic and nondiabetic animals for each of six compound genotypes. The table shows that although Iddm14 was required for diabetes,
its effect on susceptibility to diabetes was dependent on the presence of Iddm37L alleles. In the absence of Iddm37, the diabetogenicity of
Iddm14 is substantially less powerful. Iddm37, therefore, conditions the penetrance of Iddm14. *The signiﬁcance of Iddm14 in the
Iddm37L/L cohort is P  0.006. †The signiﬁcance of Iddm14 in the Iddm37L/W cohort is P  0.0001. ‡There is no signiﬁcance of Iddm14
in the Iddm37W/W cohort, P  0.106.
Diabetes in (LEW.1WR1 x WF)F2 Rats
Iddm14
L/-
 Iddm37-Heterozygous (N=59)
Iddm14
L/-
 Iddm37-LEW.1WR1 Homozygous (N=26)
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L/-
 Iddm37-WF Homozygous (N=44)
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FIG. 2. (LEW.1WR1  WF) F2 rats were subjected to the diabetes induction protocol described in RESEARCH DESIGN AND METHODS. Diabetes was
observed to occur only in those 129 animals that expressed at least one LEW.1WR1-derived allele of Iddm14 (Iddm14
L/; RESULTS). Shown is a
Kaplan-Meier diabetes-free survival plot for the these 129 rats stratiﬁed according to Iddm37 genotype. The ﬁgure shows that the presence of one or
two copies of Iddm37-L favors development of diabetes. Comparisons: overall, the three groups are highly signiﬁcantly different by log-rank analysis,
P < 0.001; Iddm37 heterozygotes vs. Iddm37 L/L, P  NS; Iddm37 heterozygotes vs. Iddm37 W/W, P < 0.001; Iddm37 L/l vs. Iddm37 W/W, P  0.015.
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LEW.1WR1 rats and their three parental strains were
identiﬁed. The strain distribution pattern of SNP alleles for
genes in the RT1C region indicates that the majority of
LEW.1WR1 alleles are of LEW.1A origin, consistent with
the original mapping (Table 3).
The Iddm37 region includes the gene for diubiquitin
(UBD), a candidate gene of interest because it resides in a
region that is homologous to mouse and human diabetes-
promoting intervals (40,41). We therefore sequenced the
complete UBD gene in the strains we studied. This re-
sulted in the identiﬁcation of two major coding region
haplotypes of UBD that we designate the “A” haplotype
(LEW.1A, LEW.1WR1) and the “L” haplotype (LEW, WF,
LEW.1W) (Fig. 4). The two UBD haplotypes contain exten-
sive SNPs in the two exons and single UBD intron (Table
3), and there is a simple-sequence length polymorphism
upstream of the 5	 end of UBD. However, only two UBD
SNPs result in nonsynonymous changes. One substitution
of histidine for arginine in the NH2-terminal domain at
amino acid 9 (SNP no. 18) (Table 3) is conservative in that
other mammalian UBD sequences include either amino
acid at this residue (online appendix Table 2). Interest-
ingly, the LEW.1WR1 and LEW.1A strains have another
SNP (no. 22) (Table 3) that encodes an amino acid change
in the COOH-terminal of UBD protein (changing an aspar-
agine to a histidine at residue 145 [N145H]). This residue is
not seen in any other mammalian UBD sequence available
for comparison (online appendix Table 2). Indeed, the
peptide sequence containing amino acid 145N in the rat
UBD-W haplotypes is conserved in rat, mouse, C. elegans,
and S. cerevisiae; human and porcine UBD have glycine in
at this position.
Expression of UBD in diabetic versus nondiabetic
animals. In a pilot study designed to quantify UBD
expression during the course of diabetes onset, we took
advantage of the fact that diabetes can be induced in 100%
of LEW.1WR1 rats by chronic treatment with poly I:C
alone (22). LEW.1WR1 rats were injected with poly I:C (1
g/g three times weekly), and, as expected (22), 100%
(12/12) developed hyperglycemia between days 12 and 14.
As would be predicted by the fact that they do not have an
RT1u class II haplotype (28), no identically treated LEW
control rats developed diabetes. In a separate experiment,
LEW.1WR1 and LEW rats were either untreated or treated
with poly I:C three times weekly as described above.
Spleens and pancreatic lymph nodes (PLNs) were col-
lected from one to six LEW.1WR1 and LEW rats on day 0
(before any poly I:C) and on days 3, 5, 8, 10, and 12 after
the ﬁrst injection of poly I:C. The level of UBD mRNA as a
percentage of a control gene product, GAPDH, was as-
sessed by quantitative real-time RT-PCR.
UBD mRNA expression in PLN cells and spleen was
higher in LEW.1WR1 rats than in LEW rats at every time
point studied (Fig. 5A). In the case of spleen cells, UBD
mRNA levels were lower overall than in PLN cells, but they
increased progressively during treatment with poly I:C. In
the PLN cells, levels did not increase appreciably during
the course of poly I:C injections. Our observation that
UBD mRNA expression was higher in LEW.1WR1 than in
LEW rats at every time point including on day 0 suggests
that there is a genetic predisposition to higher UBD levels
in LEW.1WR1 rat lymphoid tissues.
To lend support to this hypothesis, we next excluded
the possibility that the substantially lower UBD mRNA
expression in LEW rat tissues was due to the absence of
IFN-
 or TNF-, known inducers of UBD (42). Simulta-
neous testing of the cDNA from the same rat spleen
samples showed comparable levels of IFN-
 and TNF-
transcripts in both LEW and LEW.1WR1 samples (Fig.
5B). Thus, the allelic coding region polymorphisms seen in
the LEW.1WR1 and LEW rat UBD genes, and not differ-
Chromosome 8 LRO 17.0
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FIG. 3. Latency among sick animals is linked to a QTL on distal chromosome 8. The likelihood ratio statistic of this QTL, located in the interval
that contains the Iddm24 locus (38), achieves independent signiﬁcance for linkage in the present KRV-induced diabetes study. The horizontal line
indicates a “suggestive” cutoff threshold.
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statistically signiﬁcant differences in UBD gene transcript
levels. In addition, TNF- is thus unlikely to be a strong
candidate gene for Iddm37.
DISCUSSION
These data shed new light on the genetics of autoimmune
disease in the rat models of human type 1 diabetes. They
TABLE 3
SNPs in Iddm37 in four rat strains
Position LEW.1WR1 WF LEW.1W LEW.1A
Donor to
LEW.1WR1
Background
strain
(LEW) SNP
ENSRNOSNP2803333 520,944 C GG C LEW.1A G Noncoding
D20Wox18 698,147 150 155 155 150 LEW.1A 150 —
D20Got3 1,402,527 150 170 170 150 LEW.1A 170 —
UBD (SNP 22)* 1,476,122 C AA C LEW.1A A UBD coding*
UBD (SNP 21) 1,476,176 A AA A LEW.1A T UBD noncoding
UBD (SNP 20) 1,476,198 C TT C LEW.1A T UBD noncoding
UBD (SNP 19) 1,476,363 T CC T LEW.1A C UBD noncoding
UBD (SNP 18)* 1,476,529 G AA G LEW.1A A UBD coding*
UBD (SNP 17) 1,476,872 C DEL DEL C LEW.1A DEL UBD noncoding
UBD (SNP 16) 1,476,873 G AA G LEW.1A A UBD noncoding
UBD (SNP 15) 1,476,897 G AA G LEW.1A A UBD noncoding
UBD (SNP 14) 1,476,926 G AA G LEW.1A A UBD noncoding
UBD (SNP 13) 1,477,157 A GG A LEW.1A G UBD noncoding
UBD (SNP 12) 1,477,164 G AA G LEW.1A A UBD noncoding
UBD (SNP 11) 1,477,184 C TT C LEW.1A T UBD noncoding
UBD (SNP 10) 1,477,191 C TT C LEW.1A T UBD noncoding
UBD (SNP 9) 1,477,224 T CC T LEW.1A C UBD noncoding
UBD (SNP 8) 1,477,230 G AA G LEW.1A A UBD noncoding
UBD (SNP 5) 1,477,370 A CC A LEW.1A C UBD noncoding
UBD (SNP 4) 1,477,524 C TT C LEW.1A T UBD noncoding
UBD (SNP 3) 1,477,687 T CC T LEW.1A C UBD noncoding
UBD (SNP 2) 1,477,714 T CC T LEW.1A C UBD noncoding
UBD (SNP 1) 1,477,718 G AA G LEW.1A A UBD noncoding
D20Rat47 1,516,333 131 135 135 131 LEW.1A 131 —
D20Rat46 3,039,000 160 174 170 160 LEW.1A 150 —
ENSRNOSNP2803355 3,067,787 G AA G LEW.1A G Flot1 noncoding
AIF1 3,714,566 T CC T LEW.1A C AIF1 coding
ENSRNOSNP2803365 3,816,348 T CC T LEW.1A C Clic1 noncoding
rs8154092 3,955,709 A CC A LEW.1A A Hspa1b noncoding
rs8154089 3,956,875 C TT C LEW.1A - Hspa1 coding
SNP 3956957 3,956,957 T GG T LEW.1A -—
Hsp70 3,957,645 C -GC LEW.1A - Unknown
rs8163033 3,964,007 C TT C LEW.1A T Unknown
rs13456239 3,999,462 T CC T LEW.1A T Unknown
rs13456241 3,999,719 A TT A LEW.1A A Unknown
ENSRNOSNP2803370 4,071,738 G G G A LEW.1W A C2 noncoding
RT1D 4,636,358 RT1u RT1u RT1u RT1a LEW.1W RT1L RT1 class II
RT1B 4,730,559 RT1u RT1u RT1u RT1a LEW.1W RT1L RT1 class II
ENSRNOSNP2803385 4,924,504 C C C T LEW.1W T Col11a2 coding
RT1A 5,056,771 RT1u RT1u RT1u RT1a LEW.1W RT1L RT1 class I
ENSRNOSNP2803403 6,156,925 G A G A LEW.1W G Anks1a noncoding
ENSRNOSNP2803427 8,182,794 C C C A LEW.1W A Mdga1 noncoding
ENSRNOSNP2803448 9,643,317 G G G A LEW.1W G Rsph1 noncoding
ENSRNOSNP2803464 10,602,251 C C C T LEW.1W T Nnp1 coding
Icos-ligand 10,981,192 A A A C LEW.1W C Icos-ligand Intron
AIRE 10,985,967 C C C T LEW.1W T AIRE coding
ENSRNOSNP2803475 11,528,162 C C C T LEW.1W T RGD1311257 coding
D20Rat3 11,900,000 138 146 138 158 LEW.1W 158 —
D20Rat 10 34,000,000 162 156 162 162 LEW 162 —
SNPs were identiﬁed in the Iddm37 and linked RT1 loci in LEW.1WR1 (RT1AuB/DuCa), LEW.1W (RT1AuB/DuCu), LEW.1A (RT1AaB/DaCa),
and WF (RT1AuB/DuCu) rats by sequencing and phototyping as described in RESEARCH DESIGN AND METHODS. Column 7 indicates the donor of
each allele to the LEW.1WR1 rat. The polymorphic nucleotides at each position are listed. The right-most column gives the gene, if any, in
which the SNP is located and whether it is known to be a coding region polymorphism. Starred coding nucleotides result in amino acid
changes in UBD. Microsatellite markers were scored for size, and the length in nucleotides is given. RT1 alleles are given for reference, and
deletions are indicated as “DEL.” The horizontal line at 4 Mb indicates the breakpoint for RT1C. RT1C is an old term for a region that
contains many genes, and it is proximal to this breakpoint. UBD and other genes in LEW.1WR1 in this region are derived from LEW.1A, not LEW.
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susceptibility locus. In addition, they identify a new locus,
Iddm37, which plays a role in susceptibility to disease that
is triggered by the diabetogenic KRV parvovirus in
LEW.1WR1 rats.
Insulitis and diabetes both segregate with Iddm14 in the
LEW.1WR1  WF intercross, as they are already known to
do in BBDR  WF crosses (25). This observation makes
Iddm14 one of the most consistent and powerful diabetes
susceptibility loci observed in analyses in which WF or
F344 rat strains are used as the nondiabetic partner strain
(43,44). Strictly speaking, of course, we cannot claim that
the speciﬁc susceptibility gene or genes associated with
the Iddm14 region in BB and LEW.1WR1 rats are identical
until they have been cloned, but the peak marker of this
susceptibility locus in both strains is the same. Candidates
for Iddm14 include the T-cell receptor  (Tcrb-V) chain
variable region gene family, especially TcrbV13. Interest-
ingly, LEW.1WR1 rats have the same Tcrbv13 allele as
BBDR rats (43).
The QTL most clearly responsible for enhancing diabe-
tes penetrance among rats that had both permissive
Iddm14 alleles and insulitis in the KRV-exposed BBDR 
WF progeny was Iddm20 on chromosome 17 (25);
“A” HAPLOTYPE (LEW.1WR1 and LEW.1A)
MASCVCVVRSEQWPLMTFDTTMSDKVKKINEHIRSQTKVSVQDQILLLDSKILKPHRALS
SYGIDKENTIHLTLKVVKPSDEELPLSLVESGDEGQRHLLRVRRSSSVAQVKEMIENVTAVP
PKKQIVNCNGKRLEDGKIMADYHIKSGSLLFLTAHCIGG
“L” HAPLOTYPE (WF, LEW.1W, and LEW )
MASCVCVVHSEQWPLMTFDTTMSDKVKKINEHIRSQTKVSVQDQILLLDSKILKPHRALS
SYGIDKENTIHLTLKVVKPSDEELPLSLVESGDEGQRHLLRVRRSSSVAQVKEMIENVTAVP
PKKQIVNCNGKRLEDGKIMADYNIKSGSLLFLTAHCIGG
FIG. 4. Predicted amino acid sequences of UBD coding regions derived from cDNA sequences. Amino acid substitutions in the “A” haplotype
(LEW.1WR1 and LEW.1A) versus the “L” haplotype (LEW.1W, WF, and LEW) are shown in bold underlined text. The two amino acid changes were
the result of two polymorphic nucleotides: R to H from CGT to CAT and H to N from CAC to AAC.
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FIG. 5. UBD and cytokine expression in PLN and spleen of LEW and LEW.1WR1 rats, as assessed by RT-PCR. Rats were either untreated or
injected with chronic poly I:C alone three times weekly as described in RESEARCH DESIGN AND METHODS. LEW.1WR1 rats typically become diabetic
on days 10–14 when treated with this protocol. Graphs show mRNA expression levels in rats that received no poly I:C (day 0) and in rats that
had been started on the diabetes induction protocol 3, 5, 7, 9, or 12–15 days before tissue harvest. All values are expressed as a percent of GAPDH
transcripts measured in the same sample (means  SE). A: Relative expression of UBD in tissues collected from one to six animals per strain at
each time point. Boxed comparisons show day 0 (no poly I:C) values of each sample. On day 0, the spleens from untreated LEW.1WR1 rats have
signiﬁcantly elevated UBD expression compared with LEW (P  0.0063, t test). UBD expression in treated rats over all days is signiﬁcantly
different between strains in both PLN and spleen (P  0.004; Mann-Whitney test). UBD expression was also signiﬁcantly higher as a function of
the duration of poly I:C treatment in spleens (P  0.003 in LEW.1WR1, P  0.009 in LEW; linear regression) but not in PLN (P  not signiﬁcant).
, LEW.1WR1 UBD; f, LEW UBD. B: Cytokine mRNA expression in spleens taken from the same animals. Although IFN- levels increase with time
(P  0.02, ANOVA), the levels of IFN- and TNF- do not differ between strains (P  0.72, 0.32) either before or after poly I:C exposure,
suggesting that the differences in UBD expression are not due to differences in inducing cytokine levels in each rat. , LEW.1WR1 TNF; f, LEW
TNF; ‚, LEW.1WR1 IFN-; Œ, LEW IFN-.
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susceptibility of LEW.1WR1  WF progeny. The chro-
mosome 17 Iddm20 QTL is relatively weak, and stud-
ies in WF.chr17-DR congenic rats have found that
Iddm20 is recessive in the ﬁrst three backcross gener-
ations (J.P.M., E.P.B., unpublished data). LEW.1WR1 
WF progeny require a locus on chromosome 20 for full
diabetes penetrance in Iddm14-permissive animals. The
frequency of diabetes in Iddm37 heterozygous
(LEW.1WR1  WF) F2 progeny exceeded that of both
Iddm37 L/L homozygotes and Iddm37 W/W homozygotes
in this intercross (Table 2). We therefore expect that
Iddm37 will be genetically dominant in congenic rats
bearing LEW.1WR1-derived alleles at Iddm14 and
Iddm37.
Iddm37 represents a new and interesting QTL in rats
because it is syntenic with known diabetes-associated
regions in both mouse and human genomes. In mice, three
H2-linked QTLs were observed in a study of NOD.B6
congenics (45), including Idd24, which maps between Lta
(35.3 MB) and D17Mit105 (41.4 MB) on chromosome 17.
The mouse Idd24 QTL has not yet been conﬁrmed, but the
interval contains the mouse UBD gene at 37.3 Mb.
Iddm37 is also syntenic with the high-risk locus identi-
ﬁed in a scan of HLA-linked SNPs inherited by descent
(IBD) in siblings of diabetic children in the DAISY study
(41). By eliminating genes that have shared alleles in the
linkage disequilibrium–limited HLA region, and would
thus have no differential effect on diabetes in this cohort,
only two genes remained as candidates in the supported
interval, UBD and MAS1L. Studies have revealed that
siblings who have inherited shared UBD/MAS1L alleles
IBD with the diabetic proband have a 65% likelihood of
developing type 1 diabetes; the likelihood in HLA-matched
but not IBD-matched siblings was only 15% (40,41). Of two
candidate loci, only UBD is syntenic with the Iddm37 QTL
in rats, as rat MAS1L is on chromosome 1.
UBD is a member of the family of ubiquitin-like proteins.
It has several unusual properties including two ubiquitin-
like domains. In most genera, these domains are con-
served and direct repeats of one another. In mammals,
they are homologous but nonidentical. UBD has functions
that include directing proteins to the proteasome or to the
aggresome (46) using E1 (47), E2, and E3 molecules that
are different from the usual ubiquitin pathway members. In
addition, UBD is inducible in the setting of inﬂammation.
IFN-
 and TNF- are cytokines known to increase the
expression of UBD (42). The ﬁnding that UBD gene
expression is upregulated in LEW.1WR1 rats after stimu-
lation with poly I:C, and not in LEW rats, was somewhat
unexpected because LEW rats are known to be highly
sensitive to the cytokine-inducing effect of poly I:C (48).
Direct measurement of TNF- and IFN-
 transcripts
showed that these cytokines were present in both of the
strains we studied, but only in LEW.1WR1 was UBD
upregulated. UBD upregulation in LEW.1WR1 rats may
therefore reﬂect a different response to the stimulant at
the level of the UBD gene. It is formally possible that
upregulation of UBD in LEW.1WR1 rats exposed to poly
I:C is a result rather than a cause of the inﬂammation that
will ensue in the diabetes-prone strains, but the signiﬁ-
cantly higher levels of UBD transcripts present in
LEW.1WR1 tissues before poly I:C injection and before
hyperglycemia argue against this possibility.
A more intriguing hypothesis is that the UBD allele from
LEW.1WR1 is causally associated with the failure of toler-
ance leading to autoimmune diabetes in this rat in re-
sponse to environmental stimulants such as Toll-like
receptor ligation or viral infection. UBD plays an impor-
tant role in dendritic cell maturation (49,50) and thus has
a potential role in generating autoreactive T-cells that
recognize self-peptides. It may also control key signaling
molecules in T-cells (51). In future studies, it will be of
interest to analyze dendritic cell and T-cell functionality in
rat strains that carry each of the UBD alleles that we have
identiﬁed. Similarly, it will be of interest to determine
diabetes susceptibility in other RT1u rat strains as a
function of UBD genotype.
In conclusion, we have formally conﬁrmed the role of
Iddm14 in diabetes susceptibility in a third rat strain, with
LEW.1WR1 joining the previously described BBDP and
BBDR strains. In addition, we describe a new locus,
Iddm37, that is important for KRV-triggered diabetes in
the LEW.1WR1 rat, which can now be used to model an
important human syntenic QTL identiﬁed in the DAISY
cohort. Together with other recent reports of new genetic
loci in both spontaneous (19) and induced (25) diabetes,
our data highlight the growing relevance of rat models to
the study of human type 1 diabetes.
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